Showing 6751-6760 of 23150 results for "".
Evaluating Biochemical Response in Primary Biliary Cholangitis
https://reachmd.com/programs/gi-insights/evaluating-biochemical-response-in-primary-biliary-cholangitis/54678/Primary biliary cholangitis (PBC) management relies on early initiation of ursodeoxycholic acid and ongoing assessment of biochemical response to guide care. Monitoring markers such as alkaline phosphatase, bilirubin, and liver stiffness helps identify patients at risk for disease progression and thPreparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support
https://reachmd.com/programs/frontlines-psoriasis/psoriasis-family-planning/39950/New research highlights what patients with psoriasis really want to know about family planning and pregnancy—and when they want to hear it. Discover how proactively addressing these topics can close communication gaps, improve outcomes, and empower patients during this critical life stage with hostFrom Pertussis to Polio: Why Routine Childhood Vaccination Matters More Than Ever
https://reachmd.com/programs/vaccination/from-pertussis-to-polio-why-routine-childhood-vaccination-matters-more-than-ever/37701/Despite the rarity of diseases like polio and diphtheria in the U.S., recent cases underscore that these threats persist when immunization rates decline. Meanwhile, more common infections like pertussis and hepatitis B continue to pose serious risks to unprotected children. Here to talk about the imSjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
https://reachmd.com/programs/living-rheum/sjogrens-related-dry-eye-examining-targeted-treatment-strategies/36339/Sjögren’s-related dry eye requires intensive management, often combining lubrication with anti-inflammatory therapies and other interventions to reduce symptoms and improve quality of life. Join Dr. Michelle Hessen, Assistant Professor of Ophthalmology at the Wilmer Eye Institute and a member of theGene Therapy Safety in DMD: How to Identify Common Immune Reactions
https://reachmd.com/programs/neurofrontiers/gene-therapy-safety-in-dmd-how-to-identify-common-immune-reactions/35681/Gene therapy for Duchenne muscular dystrophy (DMD) introduces a micro-dystrophin transgene to support improved protein production, but it’s not without serious risks, including myocarditis, hepatic inflammation, and myositis. Here to help raise awareness of the common immune complications associatedOral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
https://reachmd.com/programs/project-oncology/oral-contraceptives-and-endometrial-cancer-examining-a-potential-dose-response-protective-effect/35506/As rates of endometrial cancer rise globally, a 2025 meta-analysis offers compelling evidence that oral contraceptives (OCs) could significantly reduce EMC risk. Explore the findings from this new review and its potential implications for the future of patient care.Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
https://reachmd.com/programs/acc-action-center/increasing-the-use-of-sglt2i-and-glp1ra-with-remote-program-in-t2d-high-cv-or-kidney-risk/24310/ACC.24 - Can the way patients are educated and medications prescribed be improved? Alexander Blood shares the results of the DRIVE study.The Impact of RADIANT: A Deep Dive into the Study
https://reachmd.com/programs/diabetes-discourse/the-impact-of-radiant-a-deep-dive-into-the-study/15883/How do we treat patients with rare and atypical diabetes? Dive into the key findings from the RADIANT study.Interview with the Investigator
https://reachmd.com/programs/advances-chronic-kidney-disease/interview-with-the-investigator/15168/In this video we talk to Dr. Kristen Nowak, Associate Professor of the Division of Renal Diseases & Hypertension at the University of Colorado about the role of adiposity and obesity in ADPKD. This invesigator perspective is just one of the many insights available in the Nephrology ReA Perspective on Pediatric Inflammatory Bowel Disease
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/a-perspective-on-pediatric-inflammatory-bowel-disease/11753/Between 20 and 25 percent of all inflammatory bowel disease cases are diagnosed in the pediatric range. How can we help these young patients?